Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neeraj Narula

Showing results (161-170 of 204) with videos related to

Pageof 21
Sort By:
Rheumatology and Therapy|April 10, 2026
Evaluation of Injection Site Pain and Adherence in Patients Transitioning from a High to Low Volume Adalimumab Formulation (AVT02, Simlandi®) Across Multiple Indications (EASE PAIN)Dara K Shahrokh, Ronald B Vender, Charles W Lynde, et al.
International Journal of Colorectal Disease|September 20, 2024
Management of complications in patients with an ileostomy: an umbrella review of systematic reviews for the EndOTrial ConsortiumVirginia Solitano, Sudheer Kumar Vuyyuru, Yuhong Yuan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 1, 2024
Defining Endoscopic Remission in Crohn's Disease: MM-SES-CD and SES-CD Thresholds Associated With Low Risk of Disease ProgressionNeeraj Narula, Emily C L Wong, Parambir S Dulai, et al.
Inflammatory Bowel Diseases|September 26, 2024
Screen Failures and Causes in Inflammatory Bowel Disease Randomized Controlled Trials: A Study of 16 913 Screened PatientsMathieu Uzzan, Georgi Georgiev, Laurent Peyrin-Biroulet, et al.
World Journal of Gastroenterology|March 11, 2026
Comparable remission and health care use in real-world inflammatory bowel disease patients initiating originator biologics <i>vs</i> biosimilarsCristiano S Moura, Albert Etingin, Luck Lukusa, et al.
Inflammatory Bowel Diseases|April 1, 2023
Endoscopic and Histological Placebo Rates in Crohn's Disease Clinical Trials: A Systematic Review and Meta-analysisSudheer K Vuyyuru, Tran M Nguyen, Malcolm Hogan, et al.
Journal of Crohn'S & Colitis|August 5, 2022
Placebo Rates in Randomized Controlled Trials of Proctitis Therapy: A Systematic Review and Meta-Analysis Placebo Response in ProctitisTheshani A De Silva, Lotus Alphonsus, Christopher Ma, et al.
Journal of Crohn'S & Colitis|October 28, 2025
Pharmacological management of upper gastrointestinal Crohn's disease: a systematic reviewMark Chatto, Dimah Alaskar, Christopher Ma, et al.
Journal of Crohn'S & Colitis|October 22, 2022
Placebo Response Rates in Randomized Controlled Trials for Perianal Crohn's Disease: A Systematic Review and Meta-AnalysisTanmay Sharma, Christopher Ma, Rocio Sedano, et al.
Alimentary Pharmacology & Therapeutics|November 23, 2019
Prevalence of endoscopic improvement and remission according to patient-reported outcomes in ulcerative colitisParambir S Dulai, Siddharth Singh, Vipul Jairath, et al.
Pageof 21

Showing results (161-170 of 204) with videos related to

Sort By:
Pageof 21
Rheumatology and Therapy|April 10, 2026
Evaluation of Injection Site Pain and Adherence in Patients Transitioning from a High to Low Volume Adalimumab Formulation (AVT02, Simlandi®) Across Multiple Indications (EASE PAIN)Dara K Shahrokh, Ronald B Vender, Charles W Lynde, et al.
International Journal of Colorectal Disease|September 20, 2024
Management of complications in patients with an ileostomy: an umbrella review of systematic reviews for the EndOTrial ConsortiumVirginia Solitano, Sudheer Kumar Vuyyuru, Yuhong Yuan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 1, 2024
Defining Endoscopic Remission in Crohn's Disease: MM-SES-CD and SES-CD Thresholds Associated With Low Risk of Disease ProgressionNeeraj Narula, Emily C L Wong, Parambir S Dulai, et al.
Inflammatory Bowel Diseases|September 26, 2024
Screen Failures and Causes in Inflammatory Bowel Disease Randomized Controlled Trials: A Study of 16 913 Screened PatientsMathieu Uzzan, Georgi Georgiev, Laurent Peyrin-Biroulet, et al.
World Journal of Gastroenterology|March 11, 2026
Comparable remission and health care use in real-world inflammatory bowel disease patients initiating originator biologics <i>vs</i> biosimilarsCristiano S Moura, Albert Etingin, Luck Lukusa, et al.
Inflammatory Bowel Diseases|April 1, 2023
Endoscopic and Histological Placebo Rates in Crohn's Disease Clinical Trials: A Systematic Review and Meta-analysisSudheer K Vuyyuru, Tran M Nguyen, Malcolm Hogan, et al.
Journal of Crohn'S & Colitis|August 5, 2022
Placebo Rates in Randomized Controlled Trials of Proctitis Therapy: A Systematic Review and Meta-Analysis Placebo Response in ProctitisTheshani A De Silva, Lotus Alphonsus, Christopher Ma, et al.
Journal of Crohn'S & Colitis|October 28, 2025
Pharmacological management of upper gastrointestinal Crohn's disease: a systematic reviewMark Chatto, Dimah Alaskar, Christopher Ma, et al.
Journal of Crohn'S & Colitis|October 22, 2022
Placebo Response Rates in Randomized Controlled Trials for Perianal Crohn's Disease: A Systematic Review and Meta-AnalysisTanmay Sharma, Christopher Ma, Rocio Sedano, et al.
Alimentary Pharmacology & Therapeutics|November 23, 2019
Prevalence of endoscopic improvement and remission according to patient-reported outcomes in ulcerative colitisParambir S Dulai, Siddharth Singh, Vipul Jairath, et al.
Pageof 21